What is the level of liabilities of Cosmos Pharmaceutical this year?
Cosmos Pharmaceutical has a debt balance of 245.1 B JPY this year.
In 2024, Cosmos Pharmaceutical's total liabilities amounted to 245.1 B JPY, a 42.05% difference from the 172.55 B JPY total liabilities in the previous year.
Cosmos Pharmaceutical's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cosmos Pharmaceutical's financial stability, operational efficiency, and long-term viability.
By comparing Cosmos Pharmaceutical's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Cosmos Pharmaceutical's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Cosmos Pharmaceutical’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Cosmos Pharmaceutical has a debt balance of 245.1 B JPY this year.
The liabilities of Cosmos Pharmaceutical have increased by 42.05% increased compared to the previous year.
High liabilities can pose a risk for investors of Cosmos Pharmaceutical, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Cosmos Pharmaceutical has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Cosmos Pharmaceutical can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Cosmos Pharmaceutical can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Cosmos Pharmaceutical include investments, acquisitions, operating costs, and sales development.
The liabilities of Cosmos Pharmaceutical are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Cosmos Pharmaceutical can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Cosmos Pharmaceutical paid a dividend of 92.5 JPY . This corresponds to a dividend yield of about 1.22 %. For the coming 12 months, Cosmos Pharmaceutical is expected to pay a dividend of 101.34 JPY.
The current dividend yield of Cosmos Pharmaceutical is 1.22 %.
Cosmos Pharmaceutical pays a quarterly dividend. This is distributed in the months of December, June, December, June.
Cosmos Pharmaceutical paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 101.34 JPY are expected. This corresponds to a dividend yield of 1.34 %.
Cosmos Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of Cosmos Pharmaceutical from 2/1/2025 amounting to 32.5 JPY, you needed to have the stock in your portfolio before the ex-date on 11/28/2024.
The last dividend was paid out on 2/1/2025.
In the year 2023, Cosmos Pharmaceutical distributed 117.5 JPY as dividends.
The dividends of Cosmos Pharmaceutical are distributed in JPY.
Our stock analysis for Cosmos Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmos Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.